Anggot, Rogelio L.
HRN: 18-22-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2023
CEFTAZIDIME 1GM (VIAL)
09/12/2023
09/18/2023
IV
1gm
Q8H
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes